Reaktion #1389

ord-2010b52898404086bd489885248322bd

Reaktionsgleichung

Cc1c(F)c(N2CC(C)C(NC(=O)OC(C)(C)C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1
7-(3-t-butoxycarbonylamino-4-methyl-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
Cl
hydrochloric acid
Cc1c(F)c(N2CC(C)C(N)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1.Cl
7-(3-amino-4-methyl-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    EinengenAfter concentrating
  2. 2
    Sonstigethe obtained residue is recrystallized from methanol-ethyl acetate

Vorschrift

A mixture comprising 7-(3-t-butoxycarbonylamino-4-methyl-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (trans form) (120 mg), ethanol (4 ml) and 10% hydrochloric acid (4 ml) is refluxed for 30 minutes. After concentrating, the obtained residue is recrystallized from methanol-ethyl acetate to give 7-(3-amino-4-methyl-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride (trans form) (60 mg), as white powder, m.p. 272°-275° C.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05723648uspto-grants-1998_03